Exhibit 99

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of March 10, 2025.

	ABG Management Ltd.

	By:	/s/ Fan Yu
	Name:	Fan Yu
	Title:	Director

	Ally Bridge Group (NY) LLC
	By: ABG Management Ltd., its managing member

	By:	/s/ Fan Yu
	Name:	Fan Yu
	Title:	Director

	Ally Bridge MedAlpha Master Fund L.P.
	By: Ally Bridge Group (NY) LLC, its manager
	By: ABG Management Ltd., its managing member

	By:	/s/ Fan Yu
	Name:	Fan Yu
	Title:	Director

	ABG Innovation Capital Partners III GP Limited

	By:	/s/ Fan Yu
	Name:	Fan Yu
	Title:	Director

	ABG Innovation Capital Partners III GP, L.P.
	By: ABG Innovation Capital Partners III GP Limited, its general partner

	By:	/s/ Fan Yu
	Name:	Fan Yu
	Title:	Director

	Ally Bridge Group Innovation Capital Partners III, L.P.
	By: ABG Innovation Capital Partners III GP, L.P., its general partner
	By: ABG Innovation Capital Partners III GP Limited, its general partner

	By:	/s/ Fan Yu
	Name:	Fan Yu
	Title:	Director

	ABG Innovation-SO Limited

	By:	/s/ Shan-ju Yeh
	Name:	Shan-ju Yeh
	Title:	Director

	ABG Global Life Science Capital Partners V GP Limited

	By:	/s/ Shan-ju Yeh
	Name:	Shan-ju Yeh
	Title:	Director

	ABG Global Life Science Capital Partners V GP, L.P.
	By: ABG Global Life Science Capital Partners V GP Limited, its general partner

	By:	/s/ Shan-ju Yeh
	Name:	Shan-ju Yeh
	Title:	Director

	Ally Bridge Group Global Life Science Capital Partners V, L.P.
	By: ABG Global Life Science Capital Partners V GP, L.P., its general partner

	By:	/s/ Shan-ju Yeh
	Name:	Shan-ju Yeh
	Title:	Director

	ABG-SIV, L.P.
	By: ABG Global Life Science Capital Partners V GP, L.P., its general partner

	By:	/s/ Shan-ju Yeh
	Name:	Shan-ju Yeh
	Title:	Director

	ABG V-SIV Limited

	By:	/s/ Shan-ju Yeh
	Name:	Shan-ju Yeh
	Title:	Director

	Mr. Fan Yu

		/s/ Fan Yu
	Name:	Fan Yu

Aadi Bioscience, Inc. SCHEDULE 13G